Galantamine hydrobromide and Revlimid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Galantamine hydrobromide (galantamine hydrobromide) and Revlimid (lenalidomide). Common drug interactions include sepsis among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Galantamine hydrobromide and Revlimid. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Galantamine hydrobromide?

Galantamine hydrobromide has active ingredients of galantamine hydrobromide. It is often used in dementia. eHealthMe is studying from 2,418 Galantamine hydrobromide users. Check the latest studies of Galantamine hydrobromide.

What is Revlimid?

Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. eHealthMe is studying from 378,026 Revlimid users. Check the latest studies of Revlimid.

On Jul, 11, 2026

11 people who take Galantamine hydrobromide and Revlimid together, and have interactions are studied.

Galantamine hydrobromide and Revlimid drug interactions.

What are the common drug interactions of Galantamine Hydrobromide and Revlimid, by gender? *:

female:

Sepsis (a severe blood infection that can lead to organ failure and death)
Haemoglobin decreased
Inflammation
Influenza
Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents)
Pneumonia viral
Thrombocytopenia (decrease of platelets in blood)
Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
Blood glucose decreased
Chronic myeloid leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood)

male:

Asthenia (weakness)
Dizziness
Fall
Fatigue (feeling of tiredness)
Injury
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

What are the common drug interactions of Galantamine Hydrobromide and Revlimid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Diarrhoea
Anaemia (lack of blood)
Thrombocytopenia (decrease of platelets in blood)
Blood glucose decreased
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Dehydration (dryness resulting from the removal of water)
Urinary tract infection
Asthenia (weakness)
Bone marrow failure
Dizziness

What are the existing conditions these people have? *

Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 3 people, 27.27%
High Blood Pressure: 2 people, 18.18%
Refractory Anaemia (an anaemia which does not respond to treatment): 1 person, 9.09%
Pain: 1 person, 9.09%
Neuropathy Peripheral (surface nerve damage): 1 person, 9.09%
Nausea (feeling of having an urge to vomit): 1 person, 9.09%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 9.09%
Depression: 1 person, 9.09%
Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Galantamine hydrobromide and Revlimid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously